Investment Associate Life Sciences at Ackermans & van Haaren | Previously Hyloris Pharmaceuticals | PhD in Biomedical Sciences (myeloma genomics)
België
Joined June 2019
- Tweets67
- Following260
- Followers171
- Likes5.3K
Thrilled to represent Hyloris at #iDR24.
Eager to dive into discussions and explore partnerships to address unmet needs by reinventing excisting medications!
Together, we will make a difference for patients.
#REMEDI4ALL #DrugRepurposing #Hyloris
105
Dat was het dan!
Na vier jaar onderzoek heb ik afgelopen dinsdag mijn doctoraat in de biomedische wetenschappen behaald. Wat een mooi moment! Énorm dankbaar voor alle fantastische mensen op me heen.
Bijzondere dank aan promotoren Prof. Dr. Jean-Luc Rummens, prof. dr. Guy Froyen, dr. @ingrid_arijs,
jury-leden Prof. Dr. @nickbolli, prof. dr. Kim De Keersmaecker, prof. Dr. @CaersJo, prof. dr. @SomersVeerle en voorzitter prof. dr. @piet_stinissen.
@LCRCenter
1
7
Presented our poster “The dynamics of nucleotide variants in the progression from myeloma precursor conditions to multiple myeloma using targeted sequencing of serial bone marrow samples” at the 18th International Myeloma Workshop.
#IMW2021 #IMW21 #IMS #mmsm @Myeloma_Society
Looking forward to attending the 18th International Myeloma Workshop within a few weeks in Vienna and present our latest results during the Poster sessions. #IMW2021 #mmsm #MGUS #MultipleMyeloma @Myeloma_Society 🧬👩🔬
Bénedith Oben retweeted
Thanks, @NatureComms Editors for highlighting our recent paper on myeloma precursors #wgs #mmsm @DrOlaLandgren @UMiamiHealth @SylvesterCancer nature.com/collections/aahaj…
Progressive vs stable myeloma precursor conditions having a different genomic profile. Happy to see our results being published in @NatureComms
#MultipleMyeloma #mgus #smm #reseach
Recently published work by @BenedithOben, @FrancescoMaura4 and @DrOlaLandgren shows that myeloma precursors that do not progress to multiple myeloma have a distinct genomic profile and emerge later in the patient's life
#CancerResearch @NatResCancer
So proud to share our paper in @NatureComms.
Many thanks to @FrancescoMaura4, @nickbolli, Dr. Peter Campbell, Prof. Dr. Jean-Luc Rummens, Prof. dr. Guy Froyen, @ingrid_arijs, @DrOlaLandgren & other collaborators. @uhasselt @LCRCenter @JessaZiekenhuis
disq.us/t/3vrlji0
Check out our last paper on MGUS and SMM in @NatureComms: "Whole-genome sequencing reveals progressive versus stable myeloma precursor conditions as two distinct entities"@SylvesterCancer @UMiamiHealth @sloan_kettering @LaStatale @uhasselt #mmsm disq.us/t/3vrlji0 👇👇(1/18)
Bénedith Oben retweeted
Online nieuwjaarswensen delen @GLW_UHasselt @uhasselt korte terugblik van decaan @piet_stinissen en @rogajokri maar vooral hoopvol én ambitieus vooruitkijken samen met collega’s o.a. @HellingsNiels en het brede netwerk #everyindividualmatters
Bénedith Oben retweeted
Mooi portret van 3 jonge, gepassioneerde @uhasselt-onderzoekers @TianeAssia, @BenedithOben en Ben Rombaut door @mirandagijsen (@hbvl). Op wetenschapuitgedokterd.be vertellen Ben, Assia en Bénedith zelf in korte, heldere #pitch over hun #onderzoek hbvl.be/cnt/dmf20210108_9809… #ms #kanker
Read our interview @hbvl about us young researchers aiming to crack the code during our PhD!
@TianeAssia and Ben studying #MultipleSclerosis and #Alzheimers at @BIOMED_UHasselt. And me, investigating the genetic code leading to #MultipleMyeloma at @LCRCenter @JessaZiekenhuis
Bénedith Oben retweeted
Phd studente @BenedithOben
(@uhasselt en @JessaZiekenhuis) onderzoekt de genetische factoren die aan de basis liggen van de progressie van het niet-kwaadaardig voorstadium #MGUS naar Multiple Myeloom (ziekte van #Kahler). #WeAreLCRC Meer info 👇
m.hbvl.be/cnt/dmf20210108_98…
Bénedith Oben retweeted
Wat een mooi kerstgeschenk voor onze wetenschappers @LCRCenter , het academisch klinisch onderzoekscentrum van #uhasselt, @ZOLziekenhuis en @JessaZiekenhuis . Van harte bedankt aan Live a Life voor de steun aan ons onderzoek naar kanker. #wearelcrc
Live a Life schenkt €14.500 aan @LCRCenter. Al 11 jaar mogen onze onderzoekers op hun steun rekenen, en daar zijn we hen enorm dankbaar voor🙏 De donatie zal dienen voor het #kankeronderzoek dat binnen LCRC plaatsvindt. Bedankt Live a Life!
👉bit.ly/37vdZYM
Nice to see this library prep workflow being published!
Very thankful that I had the opportunity to learn this protocol, used to study whole-genome libraries from low cell numbers, during my research visit at the @sangerinstitute last year.
Congrats to the amazing team! 🧬🧪
I am pleased to present the low-input laser-capture microscopy (LCM) protocol behind the various normal tissue sequencing efforts at the @sangerinstitute
nature.com/articles/s41596-0…
Bénedith Oben retweeted
2 biologically and clinically distinct entities: Progressive Versus Stable Myeloma Precursor Disease by NGS @ASH_hematology #ASH20 #mmsm :
- It is always good to see how we can split patients with MM: such a heterogenous disease! – at Houston, TX
Excited to present our study!
Session 651. Myeloma: Biology and Pathophysiology, excluding Therapy I, today at 9 a.m. PT! #ASH20
Today @BenedithOben presents our super cool study on WGS in MGUS #msmm, providing proof of principle that WGS can accurately differentiate stable and progressive precursors independently from low disease burden @DrOlaLandgren @nickbolli @sloan_kettering @SylvesterCancer #ASH20
8
Very excited for my oral presentation of our selected abstract on Dec 7!
Too bad we cannot go to San Diego... But we will make the best of it! 🤩 #ASHFromHome
#ASH20 #MMsm #MGUS #MultipleMyeloma
@FrancescoMaura4 @nickbolli @DrOlaLandgren @ingrid_arijs @ASH_hematology @LCRCenter
Whole-Genome Sequencing Reveals Evidence of Two Biologically and Clinically Distinct Entities: Progressive Versus Stable Myeloma Precursor Disease - @BenedithOben et al. #ASH20 Abs 602 Mon, Dec 7, 2020: 9:00a ow.ly/SBlj50CtdNr #mmsm #cagenome #camoldx